NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 109 filers reported holding NURIX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250,946 | -23.2% | 31,927 | -2.4% | 0.00% | 0.0% |
| Q2 2023 | $326,733 | +104287.5% | 32,706 | -7.1% | 0.00% | 0.0% |
| Q1 2023 | $313 | -6.3% | 35,215 | +15.8% | 0.00% | 0.0% |
| Q4 2022 | $334 | -99.9% | 30,403 | +1.3% | 0.00% | -50.0% |
| Q3 2022 | $391,000 | +3.2% | 30,006 | +0.4% | 0.00% | 0.0% |
| Q2 2022 | $379,000 | -7.1% | 29,897 | +2.7% | 0.00% | 0.0% |
| Q1 2022 | $408,000 | -51.4% | 29,124 | +0.4% | 0.00% | -50.0% |
| Q4 2021 | $840,000 | -3.3% | 29,018 | +0.1% | 0.00% | -20.0% |
| Q3 2021 | $869,000 | – | 29,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $18,210,601 | 1.88% |
| DAFNA Capital Management LLC | 556,695 | $5,561,383 | 1.52% |
| Deep Track Capital, LP | 2,997,830 | $29,948,322 | 1.39% |
| Redmile Group, LLC | 2,857,309 | $28,544,517 | 1.10% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,830,497 | 0.80% |
| Boxer Capital, LLC | 1,224,892 | $12,237 | 0.57% |
| AtonRa Partners | 30,142 | $301,119 | 0.47% |
| Affinity Asset Advisors, LLC | 100,000 | $999,000 | 0.35% |
| HARVARD MANAGEMENT CO INC | 314,762 | $3,144 | 0.31% |
| WASATCH ADVISORS LP | 3,869,775 | $38,659,052 | 0.23% |